Conference Tracks
Explore the scientific themes and sessions across DrugDiscoveryX-2027
Advanced Drug Discovery & Target Identification
From disease biology to validated targets, this track explores how mechanistic insight, target confidence and emerging target classes shape early discovery strategy.
- Novel Therapeutic Target Discovery
- Target Validation
- Disease Mechanism-Based Drug Discovery
- Emerging Molecular Targets
AI & Computational Drug Discovery
A focused track on AI-enabled discovery workflows, predictive modeling and computational methods that accelerate molecule and target decision-making.
- AI-Driven Drug Design
- Generative AI for Molecule Discovery
- Machine Learning for Drug–Target Prediction
- Virtual Screening and Molecular Modeling
Medicinal Chemistry & Molecular Design
This track highlights the chemistry decisions that convert promising hits into optimized therapeutic candidates.
- Structure-Based Drug Design
- Hit-to-Lead Optimization
- Structure–Activity Relationships
- Small-Molecule Therapeutics
Drug Screening & Discovery Platforms
Platform technologies for identifying, profiling and triaging discovery assets across experimental and computational settings.
- High-Throughput Screening
- Fragment-Based Drug Discovery
- Phenotypic Screening
- Virtual and In-Silico Screening
Biologics & Next-Generation Therapeutics
A track covering biologic modalities and engineered therapeutic formats designed for greater specificity, potency and clinical utility.
- Monoclonal Antibodies
- Bispecific and Multispecific Antibodies
- Protein and Peptide Therapeutics
- Antibody–Drug Conjugates
RNA, mRNA & Nucleic Acid Drug Discovery
This track explores RNA and nucleic acid modalities, from target selection and chemistry to delivery and translational development.
- mRNA Therapeutics
- siRNA and miRNA Drugs
- RNA-Based Drug Discovery
- Nucleic Acid Delivery Strategies
Targeted Protein Degradation & Emerging Drug Modalities
A modality-focused track on protein degradation, molecular glues and next-generation approaches to historically challenging targets.
- PROTACs and Targeted Protein Degraders
- Molecular Glues
- Targeted Protein Modulation
- Next-Generation Small-Molecule Modalities
Preclinical Drug Development & Translational Science
This track connects discovery assets to translational evidence packages through preclinical evaluation, disease models and safety-readiness planning.
- In-Vitro and In-Vivo Drug Evaluation
- Disease Models for Drug Development
- Pharmacology and Toxicology
- Translational Research
Pharmacokinetics, Pharmacodynamics & ADME
A dedicated track on exposure, response, metabolism and decision tools that inform dose, schedule and candidate quality.
- Pharmacokinetic Modeling
- Pharmacodynamic Biomarkers
- Drug Metabolism and Transport
- Drug–Drug Interactions
Precision Medicine & Biomarker Discovery
This track focuses on biomarkers and diagnostics that support patient selection, response prediction and personalized treatment strategies.
- Predictive and Prognostic Biomarkers
- Patient Stratification
- Companion Diagnostics
- Biomarker-Guided Treatment
Pharmacogenomics & Genomic Medicine
A track on genomic variation, drug response and development strategies that align therapeutics with patient genetics.
- Pharmacogenomic Drug Response
- Genotype–Phenotype Relationships
- Genomics-Guided Drug Development
- Precision Dosing
Precision Oncology & Cancer Drug Development
This oncology-focused track covers biomarker-led development, targeted therapies and rational combination strategies.
- Molecularly Targeted Cancer Therapies
- Precision Oncology
- Tumor Biomarkers
- Combination and Multimodal Therapies
Clinical Trials & Innovative Drug Development
A track on modern development designs, patient-centered operations and evidence-generation models that improve clinical decision-making.
- Adaptive Clinical Trial Designs
- Patient-Centric Clinical Trials
- Real-World Evidence
- Decentralized and Digital Clinical Trials
Drug Safety, Toxicology & Regulatory Science
This track addresses safety science, toxicology methods and regulatory strategies for advancing novel therapeutic products responsibly.
- Translational Toxicology
- Drug Safety Assessment
- Pharmacovigilance
- Regulatory Strategies for Novel Therapeutics
Future Drug Discovery & Personalized Therapeutics
A forward-looking track on advanced modalities, multi-omics and personalized strategies shaping the next era of therapeutic innovation.
- Cell and Gene Therapies
- Personalized Drug Development
- Multi-Omics-Guided Therapeutics
- Next-Generation Precision Medicine
Why Multiple Tracks?
Our multi-track format lets attendees tailor their summit experience across AI discovery, medicinal chemistry, biologics, RNA therapeutics, translational science and precision oncology — with in-depth sessions and cross-discipline collaboration.